Genome-wide pathway analysis in amyotrophic lateral sclerosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Y. H. | - |
dc.contributor.author | Song, G. G. | - |
dc.date.accessioned | 2021-09-05T00:44:38Z | - |
dc.date.available | 2021-09-05T00:44:38Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1676-5680 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/96121 | - |
dc.description.abstract | The aims of this study were to identify candidate single-nucleotide polymorphisms (SNPs) and mechanisms of amyotrophic lateral sclerosis (ALS) and to generate SNP-to-gene-to-pathway hypotheses. An ALS genome-wide association study (GWAS) dataset that included 483,051 SNPs in 276 patients with ALS and 271 controls of European descent was used in this study. Identify Candidate Causal SNPs and Pathway (ICSNPathway) analysis was applied to the GWAS dataset. ICSNPathway analysis identified 19 candidate SNPs, 8 genes, and 9 pathways, which provided 8 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs9352 alters the role of chromatin assembly factor 1 subunit A in the context of the pathways of chromatin and nucleosome assembly (nominal P < 0.001, false discovery rate (FDR) = 0.001, 0.018, respectively). The second strongest was rs1046329. HILS1. chromatin assembly (nominal P < 0.001, FDR = 0.018). The third was rs11100790. SMARCA5. chromatin and nucleosome assembly (nominal P < 0.001, FDR = 0.001, 0.018, respectively). The application of ICSNPathway analysis to the ALS GWAS dataset resulted in the identification of candidate SNPs, pathways, and biological mechanisms that might contribute to ALS susceptibility. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FUNPEC-EDITORA | - |
dc.subject | ASSOCIATION | - |
dc.subject | GENETICS | - |
dc.subject | DISEASE | - |
dc.subject | DEPRESSION | - |
dc.subject | PROTEASE | - |
dc.subject | DOMAINS | - |
dc.subject | SNPS | - |
dc.subject | TOOL | - |
dc.title | Genome-wide pathway analysis in amyotrophic lateral sclerosis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Y. H. | - |
dc.contributor.affiliatedAuthor | Song, G. G. | - |
dc.identifier.doi | 10.4238/2015.June.11.19 | - |
dc.identifier.scopusid | 2-s2.0-84931264748 | - |
dc.identifier.wosid | 000357189800077 | - |
dc.identifier.bibliographicCitation | GENETICS AND MOLECULAR RESEARCH, v.14, no.2, pp.6429 - 6438 | - |
dc.relation.isPartOf | GENETICS AND MOLECULAR RESEARCH | - |
dc.citation.title | GENETICS AND MOLECULAR RESEARCH | - |
dc.citation.volume | 14 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 6429 | - |
dc.citation.endPage | 6438 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | GENETICS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | DEPRESSION | - |
dc.subject.keywordPlus | PROTEASE | - |
dc.subject.keywordPlus | DOMAINS | - |
dc.subject.keywordPlus | SNPS | - |
dc.subject.keywordPlus | TOOL | - |
dc.subject.keywordAuthor | Amyotrophic lateral sclerosis | - |
dc.subject.keywordAuthor | Pathway-based analysis | - |
dc.subject.keywordAuthor | Genome-wide association study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.